Skip to content
10-K

Annual Report

Decoy Therapeutics Inc. DCOY

0001193125-26-134897

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 17, 2026 531.97K sh
Shares Diluted FY 2025 · Dec 31, 2025 96.97K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 80.18K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$4.83M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $10.71M
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.43M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.89M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.51M
Stockholders Equity FY 2025 · Dec 31, 2023 $5.29M
Current Liabilities FY 2025 · Dec 31, 2025 $5.17M
Current Liabilities FY 2025 · Dec 31, 2024 $1.51M
Total Liabilities FY 2025 · Dec 31, 2025 $5.17M
Total Liabilities FY 2025 · Dec 31, 2024 $1.51M
Current Assets FY 2025 · Dec 31, 2025 $10.99M
Current Assets FY 2025 · Dec 31, 2024 $2.99M
Total Assets FY 2025 · Dec 31, 2025 $11.06M
Total Assets FY 2025 · Dec 31, 2024 $3.02M
Eps Diluted FY 2025 · Dec 31, 2025 −$129.10
Eps Diluted restated FY 2025 · Dec 31, 2024 −$69.54
Eps Basic FY 2025 · Dec 31, 2025 −$129.10
Eps Basic restated FY 2025 · Dec 31, 2024 −$69.54
Sga Expense FY 2025 · Dec 31, 2025 $3.73M
Sga Expense FY 2025 · Dec 31, 2024 $4.96M
Rd Expense FY 2025 · Dec 31, 2025 $368.17K
Rd Expense FY 2025 · Dec 31, 2024 $770.03K
Net Income FY 2025 · Dec 31, 2025 −$12.52M
Net Income FY 2025 · Dec 31, 2024 −$5.58M
Operating Income FY 2025 · Dec 31, 2025 −$12.61M
Operating Income FY 2025 · Dec 31, 2024 −$5.73M